Blue Horizon International Creates Stem Cell Education Broadcast for Public TV

Broadcaster Jimmy Johnson to Host Segments That Educate Public on Stem Cell Treatments

Nov 26, 2013, 19:31 ET from Blue Horizon International

NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Blue Horizon Stem Cells (BHSC) announced a strategic partnership with "Leading Edge with Jimmy Johnson", to inform public television audiences on the current status of medical stem cell treatments.

BHSC identified patient education as a primary goal for 2013.  The company named well regarded documentary film makers Leading Edge, of Pompano Beach, FL to help realize Blue Horizon's educational vision.

Blue Horizon's Founder and Chief Medical Officer Brian Mehling, MD says, "The term "stem cells" is broadly recognized and has meaning to many people.  However, stem cell research science and available treatments are not generally well understood by the public.  We hope educational efforts, like this one with public television, will help patients know that they have stem cell treatment options."

Mehling continues, "BHSC promotes education many ways.  We reach younger cohort groups through popular culture social outreach."  Mehling returned recently from Shangdong Province in Hubei China where he keynoted an academic conference on Hematopoietic Stem Cells and Leukemia.  For other market segments, the company hired the world's first supermodel, Janice Dickinson, to be spokesperson for a stem-cell-based skin care range.

John Ferguson, President and CEO of Blue Horizon International says, "Blue Horizon creates new product categories that require explanation and education to bring the public along with us."

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy.  BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved.  BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date.  For more information please visit Blue Horizon International at

Media Contact:
Odd Einer


SOURCE Blue Horizon International